 Erytech Pharma SA NASDAQ: ERYP says that the results from the NOPHO sponsored Phase 2 trial of eryaspase in acute lymphoblastic leukemia ALL patients are published in the British Journal of Haematology. The Phase 2 NOR-GRASPALL-2016 trial evaluated the safety and pharmacological. 